Karin Jooss

(DR. Karin Jooss Ph.D.)

Currently holds positions in Gritstone Oncology Inc and Fate Therapeutics Inc

Positions
Position Company Period
Executive Vice President - Research, Chief Scientific Officer Gritstone Oncology Inc April 1, 2016 -
Independent Director Fate Therapeutics Inc March 18, 2019 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-06-06 2022-06-03
S Sale
1,483 -55.3%
22.82
33,842 USD 		1,483 -55.3% 22.82 33,842 USD